Brian A. Pryor

Chief Executive Officer at LiteCure LLC

Health Technology

Profile

Brian A.
Pryor is the founder of LiteCure LLC, where he currently holds the title of Chief Executive Officer.
He also currently works as a Director at Nanospectra Biosciences, Inc.

Brian A. Pryor active positions

Companies	Position	Start
LiteCure LLC LiteCure LLC Medical SpecialtiesHealth Technology LiteCure LLC manufactures and distributes medical devices. Its products include LightForce EX, LightForce Pro, LCT-1000, Compass and Empower DS. The firm is a registered manufacturer providing FDA cleared products for a variety of medical applications. The company was founded by Brian A. Pryor and Sean X. Wang in October 2007 and is headquartered in Newark, DE.	Chief Executive Officer	01/01/2007
Nanospectra Biosciences, Inc. Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX.	Director/Board Member	-

All active positions of Brian A. Pryor

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brian A. Pryor's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
LiteCure LLC LiteCure LLC Medical SpecialtiesHealth Technology LiteCure LLC manufactures and distributes medical devices. Its products include LightForce EX, LightForce Pro, LCT-1000, Compass and Empower DS. The firm is a registered manufacturer providing FDA cleared products for a variety of medical applications. The company was founded by Brian A. Pryor and Sean X. Wang in October 2007 and is headquartered in Newark, DE.	Health Technology
Nanospectra Biosciences, Inc. Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX.	Health Technology